Inhaled β2-agonists in asthma management: an evolving story

Inhaled β2-agonists in asthma management: an evolving story

Bibliographic Details
Main Authors:	Diana Silva, Tiago Jacinto
Format:	Article
Language:	English
Published:	European Respiratory Society 2016-12-01
Series:	Breathe
Online Access:	http://breathe.ersjournals.com/content/12/4/375.full

Similar Items

β2-agonists in asthma
by: Britton, J, et al.
Published: (1991)

Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled β2-agonists in patients with asthma, COPD or asthma-COPD overlap
by: Joseph Emil Amegadzie, et al.
Published: (2022-12-01)

Combined therapy with inhaled glucocorticosteroids and long-acting β2-agonists in patients with bronchial asthma: the problem of choice
by: A. I. Sinopalnikov
Published: (2021-10-01)

Cost effectiveness of tiotropium in patients with asthma poorly controlled on inhaled glucocorticosteroids and long-acting β-agonists
by: Willson, J, et al.
Published: (2014)

Cost effectiveness of tiotropium in patients with asthma poorly controlled on inhaled glucocorticosteroids and long-acting β-agonists.
by: Willson, J, et al.
Published: (2014)

Impact of adherence to treatment with inhaled corticosteroids/long-acting β-agonists on asthma outcomes in the United States
by: Carlyne M. Averell, et al.
Published: (2022-08-01)

Effect of 443c81, an inhaled mu-opioid receptor agonist in asthma.
by: Pavord, I, et al.
Published: (1994)

Combination fixed-dose β agonist and steroid inhaler as required for adults or children with mild asthma: a Cochrane systematic review
by: Crossingham, I, et al.
Published: (2021)

The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis
by: Pavord, I, et al.
Published: (2017)

Long-acting β2-adrenergic receptor agonist in pediatric asthma
by: Shigemi Yoshihara, et al.
Published: (2004-01-01)

Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma–COPD overlap syndrome
by: Lee SY, et al.
Published: (2016-11-01)

Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma
by: Crossingham, I, et al.
Published: (2020)

Combination fixed‐dose beta agonist and steroid inhaler as required for adults or children with mild asthma
by: Crossingham, I, et al.
Published: (2021)

Effect of Inhaled β2-Agonist on Exhaled Nitric Oxide in Chronic Obstructive Pulmonary Disease.
by: Mostafa Amer, et al.
Published: (2016-01-01)

Beta 2-agonists in asthma.
by: Britton, J, et al.
Published: (1991)

Management of chronic obstructive pulmonary disease: Insights into patient profile – Use of inhaled corticosteroids/long-acting β2-Agonists or long-acting β2-agonists/long-acting muscarinic antagonists
by: Nevin Kishore, et al.
Published: (2020-01-01)

Allosteric modulator potentiates β2AR agonist–promoted bronchoprotection in asthma models
by: Seungkirl Ahn, et al.
Published: (2023-09-01)

It is time to end our love affair with short-acting β2-agonists in asthma
by: Michael G. Crooks, et al.
Published: (2022-10-01)

Short-acting β2-agonists and exacerbations in children with asthma in England: SABINA Junior
by: Ann Morgan, et al.
Published: (2023-04-01)

Bronchodilator Responsiveness Measured by Spirometry and Impulse Oscillometry in Patients with Asthma After Short Acting Antimuscarinic and/or Beta-2-Agonists Inhalation
by: van der Burg NMD, et al.
Published: (2024-01-01)

AIDS: the evolving story.
by: Phillips, R, et al.
Published: (2000)

It is time to end our love affair with short-acting β2-agonists in asthma? Yes
by: Luis J. Nannini
Published: (2023-02-01)

Optimal follow-up period after switching to another inhaled corticosteroid/long-acting β2 agonist in patients with asthma: A retrospective study using Japanese administrative claims data
by: Rieko Kondo, et al.
Published: (2022-01-01)

Optimal follow-up period after switching to another inhaled corticosteroid/long-acting β2 agonist in patients with asthma: A retrospective study using Japanese administrative claims data.
by: Rieko Kondo, et al.
Published: (2022-01-01)

Inhaled medications and inhalation chambers for childhood asthma. Spanish network of working groups on asthma in pediatrics (REGAP)
by: Juan Carlos Juliá Benito, et al.
Published: (2024-02-01)

Combination long acting β agonists-inhaled corticosteroids versus dual bronchodilation: a real conflict?
by: Marco Candela
Published: (2014-10-01)

Effective respiratory management of asthma and COPD and the environmental impacts of inhalers
by: Omar S. Usmani, et al.
Published: (2023-07-01)

Estimating Inhaled Corticosteroid Exposure from Short-Acting β2-Agonist–Inhaled Corticosteroid Rescue
by: Lugogo N, et al.
Published: (2023-05-01)

Healthcare costs associated with short-acting β2-agonists in asthma: observational UK SABINA study
by: Darush Attar-Zadeh, et al.
Published: (2023-09-01)

Reply to: inhaled corticosteroids and adult asthma
by: Beasley, R, et al.
Published: (2019)

Effect of monitoring adherence to regular inhaled corticosteroid (ICS) alone or in combination with a long-acting β2-agonist (LABA) using electronic methods on asthma outcomes: a narrative systematic review
by: John F Marriott, et al.
Published: (2023-08-01)

Real-life effectiveness of indacaterol/glycopyrronium/mometasone for symptomatic relief of cough after switching from inhaled corticosteroid/long-acting β2-agonist therapy in patients with asthma: REACH study design
by: Akio Niimi, et al.
Published: (2023-03-01)

Exacerbations in COPD patients treated with Inhaled Corticosteroids/Long-acting β2 agonists combinations, switching to another combination drugs or inhaler device: A “real – world” study
by: Diego Sangiorgi, et al.
Published: (2017-01-01)

Pharmacogenetics of β2-Agonists
by: Nobuyuki Hizawa
Published: (2011-01-01)

Asthma control in patients receiving inhaled corticosteroid and long-acting beta<sub>2</sub>-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation
by: Nicolini Gabriele, et al.
Published: (2011-07-01)

Effect of inhaled prostaglandin E2 on allergen-induced asthma.
by: Pavord, I, et al.
Published: (1993)

Identifying Critical Errors: Addressing Inhaler Technique in the Context of Asthma Management
by: Sinthia Z. Bosnic-Anticevich, et al.
Published: (2018-06-01)

Montelukast versus inhaled corticosteroids in the management of pediatric mild persistent asthma
by: Scaparrotta Alessandra, et al.
Published: (2012-07-01)

Managing pollen asthma with a single inhaler: a case study
by: N. M. Nenasheva
Published: (2015-12-01)

Therapeutic drug monitoring of corticosteroids/β2-agonists in the hair of patients with asthma: an open-label feasibility study
by: Hélène Salvator, et al.
Published: (2024-01-01)